3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 5 Phase 4, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1 |
| Not applicable | 2 | Recruiting 1, Unknown 1 |
Follow Residual Neuromuscular Block: new trials by email Literature Review of Residual Neuromuscular Block trials Research Report on Residual Neuromuscular Block
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function Sugammadex, Neostigmine - Residual Neuromuscular Block | Not applicable | Recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 240 | 2025-12-30 | 2026-06-22 |
| Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia pipecuronium bromide, Rocuronium bromide - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Not yet recruiting | Tamas Vegh, MD | 80 | 2025-06-26 | 2025-06-29 |
| Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia pipecuronium bromide, Rocuronium bromide - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Active not recruiting | Tamas Vegh, MD | 80 | 2025-06-26 | 2025-08-07 |
| Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis Sevofluorane, Propofol - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Enrolling by invitation | Tamas Vegh, MD | 20 | 2024-07-06 | 2025-08-05 |
| Effects of Low-pressure Pneumoperitoneum Associated With Deep Pipecuronium-induced Neuromuscular Blockade on Hemodynamic Parameters for High Cardiovascular Risk Patient Undergoing General Anesthesia Residual Neuromuscular Block, Cardiovascular Diseases | Completed | Tamas Vegh, MD | 10 | 2023-01-08 | 2024-07-24 | |
| Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block Neuromuscular monitoring, reverse of NMB with sugammadex, reverse of NMB with Sugammadex and neostigmin low dose - Residual Neuromuscular Block, Neuromuscular Blockade Monitoring | Not applicable | Unknown | Ankara City Hospital Bilkent | 90 | 2022-02-01 | 2022-02-08 |
| Neostigmine Reversal And Neuromuscular Recovery Neostigmine Group, No Neostigmine group - Residual Neuromuscular Block | Phase 4 | Completed | Endeavor Health | 120 | 2015-04-01 | 2017-04-12 |
| Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia Cisatracurium, Rocuronium - Postoperative Residual Curarization, Residual Neuromuscular Block | Phase 4 | Completed | Azienda Ospedaliera di Padova | 120 | 2012-07-01 | 2014-03-11 |
Delayed Emergence from Anesthesia (8) · Cardiovascular Diseases (1) · Postoperative Complications (1) · Postoperative Nausea and Vomiting (1)
Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Postoperative Complications (7) · Nausea (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Vomiting (1)
Rocuronium (3) · Pipecuronium (2) · Sugammadex (2) · Neostigmine (1) · Neuromuscular Monitoring (1) · Propofol (1) · cisatracurium (1)
Tamas Vegh, MD (4) · Ankara City Hospital Bilkent (1) · Azienda Ospedaliera di Padova (1) · Endeavor Health (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
Hungary (4) · China (1) · Italy (1) · Turkey (Türkiye) (1) · United States (1)
Carlo Ori, Prof. M.D. (1) · Paolo Feltracco, M.D. (1) · Xin Lv, PhD (1)